News Releases Archive — Page 5 of 38
Recent and archived press releases with clinical and research news
-
April 22, 2026
Study finds sleep apnea may be widespread — and often underdiagnosed or undertreated — among former professional football players
Evidence further suggests untreated sleep apnea is strongly linked to worse mental, cognitive and physical health for former athletes. -
April 22, 2026
Liquid biopsy predicts response to breast cancer immunotherapy
This minimally invasive and cost-effective alternative to tissue biopsy offers “an accessible tool for tailoring treatment strategies in breast cancer,” researchers reported April 22 in the journal Science Translational Medicine. -
April 22, 2026
Child Health Poll: Vast majority of Tennessee parents say their kids get regular immunizations, support school-based immunization requirements
Roughly 8 in 10 parents surveyed across the state said they are concerned about communicable diseases like measles if others are not immunized and agreed that immunizations are important to protect their children from serious infections. -
April 20, 2026
Local students circle the wagons in relaunch of donation initiative
The Red Wagon Project, established in 2012, is a volunteer program for students in grades K-12: They spearhead donation drives to benefit families during their hospital stay. -
April 20, 2026
Drug lifts ‘brain fog’ from lupus patients: Clinical trial
An estimated 200,000 people in the United States have lupus. About 80% of them experience “brain fog,” cognitive problems that impair learning, memory and attention. -
April 18, 2026
Rapid bloodstream infection testing shows high potential for timely, lifesaving treatment: Study
Gram-negative bacteria bloodstream infections are a major cause of illness and death worldwide, especially where antimicrobial resistance is more common. -
April 17, 2026
C. diff study enrolling patients over 65 at increased risk of infection
Participants in the BEETHOVEN study will be randomized to receive two C. difficile vaccine doses six months apart, or a placebo, to learn if an investigational vaccine is safe and can help prevent C. difficile infection in people age 65 and older.